Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine for treatment of schizophrenia
IRCT2012101011076N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of venlafaxine in schizophrenia, sponsored by Kurdistan University of Medical Sciences. Started May 2013; status: completed.
02
Drugs
venlafaxine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT2012101011076N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2012101011076N1.